Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model

Journal of Translational Medicine

Volumn 15, Issue 1, 2017, Pages

  Hosgood, Sarah A ^a   Moore, Tom ^a   Kleverlaan, Theresa ^a   Adams, Tom ^a   Nicholson, Michael L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ex vivo perfusion; Haemoadsorption; Inflammation; Kidney

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROSTAGLANDIN E2; THROMBOXANE; TUMOR NECROSIS FACTOR; CYTOKINE; HEME; HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; EX VIVO STUDY; EXPERIMENTAL MODEL; GENE EXPRESSION; HEMADSORPTION; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; KIDNEY TISSUE; NONHUMAN; PIG; URINE SAMPLING; ADSORPTION; ANIMAL; ANIMAL MODEL; BLOOD; BLOOD FLOW; GENE EXPRESSION REGULATION; GENETICS; HEMATOCRIT; HEMODYNAMICS; KIDNEY; KIDNEY FUNCTION TEST; LEUKOCYTE COUNT; METABOLISM; PATHOLOGY; PERFUSION; PHYSIOLOGY; PLATELET COUNT; VASCULARIZATION;

ADSORPTION; ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; HEMATOCRIT; HEME; HEMODYNAMICS; HEMOGLOBINS; INFLAMMATION; KIDNEY; KIDNEY FUNCTION TESTS; LEUKOCYTE COUNT; MODELS, ANIMAL; PERFUSION; PLATELET COUNT; REGIONAL BLOOD FLOW; SUS SCROFA;

EID: 85032221131     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-017-1314-5     Document Type: Article

References (31)

1. Nicholson ML, Hosgood SA. Renal transplantation after ex vivo normothermic perfusion: the first clinical study. Am J Transplant. 2013;13(5):1246-52.
2. Barbas AS, Goldaracena N, Dib MJ, Selzner M. Ex-vivo liver perfusion for organ preservation: recent advances in the field. Transplant Rev. 2016;30(3):154-60.
3. Cypel M, Keshavjee S. Extracorporeal lung perfusion (ex vivo lung perfusion). Curr Opin Organ Transplant. 2016;21(3):329-35.
4. Hosgood SA, Patel M, Nicholson ML. The conditioning effect of ex vivo normothermic perfusion in an experimental kidney model. J Surg Res. 2013;182:153-60.
5. Bagul A, Hosgood SA, Kaushik M, Kay MD, Waller HL, Nicholson ML. Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. Br J Surg. 2008;95(1):111-8.
6. Hosgood SA, Barlow AD, Hunter JP, Nicholson ML. Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants. Br J Surg. 2015;102(11):1433-40.
7. Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev. 2015;4:20-7.
8. Yano T, et al. The pathological role of IL-18Rα in renal ischemia/reperfusion injury. Lab Invest. 2015;95:78-91.
9. Jang HR, Ko GJ, Wasowska BA, Rabb H. The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med. 2009;87:859-64.
10. Kamińska D, et al. The influence of warm ischemia elimination on kidney injury during transplantation-clinical and molecular study. Sci Rep. 2016;6:36118.
11. Datta N, Devaney SG, Busuttil RW, Azari K, Kupiec-Weglinski JW. Prolonged cold ischemia time results in local and remote organ dysfunction in a murine model of vascularized composite transplantation. Am J Transplant. 2017. doi: 10.1111/ajt.14290.
12. Kogelmann K, Jarczak D, Scheller M, Drüner M. Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care. 2017;21:74. doi: 10.1186/s13054-017-1662-9.
13. Träger K, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016;39:141-6.
14. Houschyar KS, Nietzschmann I, Siemers F. The use of a cytokine adsorber (CytoSorb) in a patient with septic shock and multi-organ dysfunction (MODS) after a severe burn injury. Handchir Mikrochir Plast Chir. 2017;49:123-6.
15. David S, Thamm K, Schmidt BMW, Falk CS, Kielstein JT. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. J Intensive Care. 2017;5:12. doi: 10.1186/s40560-017-0208-1.
16. Bernardi MH, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery-a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016;20:96. doi: 10.1186/s13054-016-1270-0.
17. Menke J, Sollinger D, Schamberger B, Heemann U, Lutz J. The effect of ischemia/reperfusion on the kidney graft. Curr Opin Organ Transplant. 2014;19:395-400.
18. Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009;2009:137072.
19. Thurman JM. Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol. 2007;123:7-13.
20. Houschyar KS, et al. Continuous hemoadsorption with a cytokine adsorber during sepsis-a review of the literature. Int J Artif Organs. 2017;40:205-11.
21. Lutz J, Thürmel K, Heemann U. Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm. 2010;7:27. doi: 10.1186/1476-9255-7-27.
22. Lawrence T. The nuclear factor NF-ΚB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi: 10.1101/cshperspect.a001651.
23. Gabryšová L, Howes A, Saraiva M, O'Garra A. The regulation of IL-1 expression. Curr Top Microbiol Immunol. 2014;380:157-90.
24. Frangogiannis NG, et al. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 1998;30:2567-76.
25. Rusai K, et al. Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury. Transpl Int. 2008;21:572-80.
26. Hosgood SA, Nicholson ML. An assessment of urinary biomarkers in a series of declined human kidneys measured during ex vivo normothermic kidney perfusion. Transplantation. 2016. doi: 10.1097/TP.0000000000001504.
27. Au V, Feit J, Barasch J, Sladen RN, Wagener G. Urinary neutrophil gelatinase-associated lipocalin (NGAL) distinguishes sustained from transient acute kidney injury after general surgery. Kidney Int Rep. 2016;1:3-9.
28. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31:986-1000.
29. Yun SH, Sim EH, Goh RY, Park JI, Han JY. Platelet activation: the mechanisms and potential biomarkers. Biomed Res Int. 2016;9060143:2016. doi: 10.1155/2016/9060143.
30. Immenschuh S, Vijayan V, Janciauskiene S, Gueler F. Heme as a target for therapeutic interventions. Front Pharmacol. 2017;8:146. doi: 10.3389/fphar.2017.00146.
31. Iskender I, et al. Cytokine filtration modulates pulmonary metabolism and edema formation during ex vivo lung perfusion. J Heart Lung Transplant. 2017;17(S1053-2498):31802-8.